文献速递前列腺癌

单侧磁共振成像病灶男性接受磁共振-超声融合靶向前列腺穿刺活检时同侧与对侧经直肠超声引导系统穿刺活检的作用

The Role of Ipsilateral and Contralateral Transrectal Ultrasound-guided Systematic Prostate Biopsy in Men With Unilateral Magnetic Resonance Imaging Lesion Undergoing Magnetic Resonance Imaging-ultrasound Fusion-targeted Prostate Biopsy.
PubMed 文献 · Urology · 2016-11-18

本研究纳入211例单侧磁共振成像(MRI)病灶并接受系统穿刺活检(SB)和磁共振-超声融合靶向活检(MRF-TB)的病例,分别分析靶向、同侧系统穿刺和对侧系统穿刺组织。结果显示MRI怀疑评分与任何前列腺癌、Gleason 6及Gleason >6前列腺癌检出率呈直接关系;MRF-TB+同侧SB检出96.0%临床显著前列腺癌,避免检出18.6%临床不显著前列腺癌;MRF-TB+对侧SB检出81.6%临床显著前列腺癌,避免检出30.2%临床不显著前列腺癌。作者认为同侧SB应加入MRF-TB,对侧SB可暂缓。

要点

  • MRI怀疑评分与任何前列腺癌、Gleason 6及Gleason >6前列腺癌检出率呈直接关系。
  • MRF-TB+同侧SB检出96.0%临床显著前列腺癌,避免检出18.6%临床不显著前列腺癌。
  • MRF-TB+对侧SB检出81.6%临床显著前列腺癌,避免检出30.2%临床不显著前列腺癌。

核心结论

  • 作者认为同侧系统穿刺活检应加入磁共振-超声融合靶向活检,因为临床显著前列腺癌检出率增加而临床不显著前列腺癌检出仅适度增加。
  • 作者认为在此情况下对侧系统穿刺活检可暂缓,因其主要检出临床不显著前列腺癌。

研究设计与样本

  • 共211例单侧磁共振成像病灶病例接受系统穿刺活检和磁共振-超声融合靶向活检。
  • 磁共振-超声融合靶向活检、同侧系统穿刺活检和对侧系统穿刺活检的组织芯分别进行分析。

主要发现

  • 磁共振-超声融合靶向活检单独、联合同侧系统穿刺活检、联合对侧系统穿刺活检分别检出全部前列腺癌的64.1%、89.1%、76.1%。
  • 磁共振-超声融合靶向活检单独、联合同侧系统穿刺活检、联合对侧系统穿刺活检分别检出Gleason 6前列腺癌的53.5%、81.4%、69.8%。
  • 磁共振-超声融合靶向活检单独、联合同侧系统穿刺活检、联合对侧系统穿刺活检分别检出Gleason >6前列腺癌的73.5%、96.0%、81.6%。
  • 磁共振-超声融合靶向活检联合同侧系统穿刺活检检出96.0%临床显著前列腺癌,避免检出18.6%临床不显著前列腺癌。
  • 磁共振-超声融合靶向活检联合对侧系统穿刺活检检出81.6%临床显著前列腺癌,避免检出30.2%临床不显著前列腺癌。

临床怎么用

  • 作者认为同侧系统穿刺活检应加入磁共振-超声融合靶向活检。
  • 作者认为在此情况下对侧系统穿刺活检可暂缓。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine how ipsilateral (ipsi) and contralateral (contra) systematic biopsies (SB) impact detection of clinically significant vs insignificant prostate cancer (PCa) in men with unilateral magnetic resonance imaging (MRI) lesion undergoing MRI-ultrasound fusion-targeted biopsy (MRF-TB). MATERIALS AND METHODS: A total of 211 cases with 1 unilateral MRI lesion were subjected to SB and MRF-TB. Biopsy tissue cores from the MRF-TB, ipsi-SB, and contra-SB were analyzed separately. RESULTS: A direct relationship was observed between MRI suspicion score and (1) detection of any cancer, (2) Gleason 6 PCa, and (3) Gleason >6 PCa. MRF-TB alone, MRF-TB + ipsi-SB, and MRF-TB + contra-SB detected 64.1%, 89.1%, and 76.1% of all PCa, respectively; 53.5%, 81.4%, and 69.8% of Gleason 6 PCa, respectively; and 73.5%, 96.0%, and 81.6% of Gleason >6 PCa, respectively. MRF-TB + ipsi-SB detected 96% of clinically significant PCa and avoided detection of 18.6% of clinically insignificant PCa. MRF-TB + contra-SB detected 81.6% of clinically significant PCa and avoided detection of 30.2% of clinically insignificant PCa. CONCLUSION: Our study suggests that ipsi-SB should be added to MRF-TB, as detection of clinically significant PCa increases with only a modest increase in clinically insignificant PCa detection. Contra-SB in this setting may be deferred because it primarily detects clinically insignificant PCa.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Bryk DJ, Llukani E, Taneja SS, et al. The Role of Ipsilateral and Contralateral Transrectal Ultrasound-guided Systematic Prostate Biopsy in Men With Unilateral Magnetic Resonance Imaging Lesion Undergoing Magnetic Resonance Imaging-ultrasound Fusion-targeted Prostate Biopsy. Urology. 2016. PMID: 27871829. doi:10.1016/j.urology.2016.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。